Injectable Biodegradable Silica Depot: Two Months of Sustained Release of the Blood Glucose Lowering Peptide, Pramlintide

Diabetes mellitus is a major healthcare challenge. Pramlintide, a peptide analogue of the hormone amylin, is currently used as an adjunct with insulin for patients who fail to achieve glycemic control with only insulin therapy. However, hypoglycemia is the dominant risk factor associated with such a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tyagi, Puneet, Koskinen, Mika, Mikkola, Jari, Sarkhel, Sanjay, Leino, Lasse, Seth, Asha, Madalli, Shimona, Will, Sarah, Howard, Victor G., Brant, Helen, Corkill, Dominic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952239/
https://www.ncbi.nlm.nih.gov/pubmed/35335929
http://dx.doi.org/10.3390/pharmaceutics14030553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952239/
https://www.ncbi.nlm.nih.gov/pubmed/35335929
http://dx.doi.org/10.3390/pharmaceutics14030553

Ejemplares similares